United Therapeutics
UTHR
UTHR
425 hedge funds and large institutions have $7.81B invested in United Therapeutics in 2022 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 145 increasing their positions, 156 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 156
15% less capital invested
Capital invested by funds: $9.17B → $7.81B (-$1.36B)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
Holders
425
Holding in Top 10
14
Calls
$68.7M
Puts
$52.1M
Top Buyers
| 1 | +$128M | |
| 2 | +$97.7M | |
| 3 | +$41.8M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$35.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$33.3M |
Top Sellers
| 1 | -$50.2M | |
| 2 | -$32.6M | |
| 3 | -$29.2M | |
| 4 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$28.9M |
| 5 |
Renaissance Technologies
New York
|
-$27.3M |